[Pathophysiology and choice of treatment in acute renal failure].
Sugimura
Kazunobu
K
Department of Urology, Osaka City University Graduate School of Medicine.
D058186:Acute Kidney Injury / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D009320:Atrial Natriuretic Factor / Q000627:therapeutic use; D001672:Biocompatible Materials; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D004815:Epidermal Growth Factor / Q000627:therapeutic use; D017583:Hemodiafiltration; D017228:Hepatocyte Growth Factor / Q000627:therapeutic use; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use; D008567:Membranes, Artificial; D006435:Renal Dialysis
D001672:Biocompatible Materials; D002121:Calcium Channel Blockers; D004232:Diuretics; D008567:Membranes, Artificial; D004815:Epidermal Growth Factor; D017228:Hepatocyte Growth Factor; D007334:Insulin-Like Growth Factor I; D009320:Atrial Natriuretic Factor; D004298:Dopamine